| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 97.27M | 118.03M | 115.25M | 167.50M | 154.10M | 178.02M |
| Gross Profit | -2.51M | 4.45M | 2.33M | 26.40M | 17.64M | 33.15M |
| EBITDA | -12.33M | -6.22M | -1.11M | -46.68M | 5.23M | 19.02M |
| Net Income | -49.14M | -38.18M | -29.38M | -74.50M | -31.00M | -3.27M |
Balance Sheet | ||||||
| Total Assets | 228.26M | 247.05M | 273.51M | 296.10M | 351.22M | 371.29M |
| Cash, Cash Equivalents and Short-Term Investments | 16.99M | 4.66M | 5.62M | 11.60M | 10.79M | 24.66M |
| Total Debt | 86.83M | 73.99M | 54.15M | 77.60M | 70.98M | 69.76M |
| Total Liabilities | 122.20M | 112.94M | 103.73M | 121.00M | 116.60M | 110.85M |
| Stockholders Equity | 106.06M | 134.11M | 169.78M | 175.10M | 234.62M | 260.44M |
Cash Flow | ||||||
| Free Cash Flow | -5.08M | -17.72M | -12.20M | -12.00M | -3.00M | 22.92M |
| Operating Cash Flow | 2.36M | -2.88M | 5.92M | 5.90M | 15.39M | 33.32M |
| Investing Cash Flow | -6.41M | -10.19M | -17.96M | -10.70M | -18.30M | -11.77M |
| Financing Cash Flow | 13.36M | 12.16M | 6.63M | 4.73M | -11.17M | -5.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $1.04B | 40.82 | 4.64% | 0.87% | -5.39% | -73.52% | |
66 Neutral | £52.74M | -23.54 | -3.85% | 4.16% | -27.57% | -130.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £48.95M | -2,681.82 | 2.28% | 3.64% | -21.33% | -11.35% | |
56 Neutral | £155.04M | 28.39 | 4.79% | 2.79% | 1.74% | 359.50% | |
44 Neutral | £17.74M | -6.51 | ― | ― | -3.25% | -172.09% | |
42 Neutral | £54.35M | -1.08 | -37.55% | ― | -24.75% | -110.79% |
IQE plc announced that as of 31 October 2025, its issued share capital consists of 977,561,878 ordinary shares, with 4,115 shares held in treasury, resulting in 977,557,763 shares with voting rights. This figure is crucial for shareholders to determine their notification requirements under the Financial Conduct Authority’s rules, reflecting the company’s transparency and regulatory compliance.
The most recent analyst rating on (GB:IQE) stock is a Hold with a £5.50 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc announced its total voting rights as of 30 September 2025, with an issued share capital of 977,552,089 ordinary shares, of which 4,115 are held in treasury. This results in 977,547,974 ordinary shares with voting rights, a figure that shareholders can use to determine the need to notify changes in their interest under the Financial Conduct Authority’s rules. This announcement provides transparency for stakeholders and ensures compliance with regulatory requirements, reinforcing IQE’s commitment to maintaining clear communication with its investors.
The most recent analyst rating on (GB:IQE) stock is a Hold with a £9.50 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc reported a challenging first half of 2025, with revenue declining to £45.3 million from £66.0 million in the previous year, primarily due to reduced demand in wireless markets and delays in US military funding. Despite these setbacks, the company has made significant strides in innovation, particularly in GaN and microLED technologies, and maintains a strong customer pipeline. IQE is undergoing a strategic review, including potential sale discussions, and is focused on cost control and operational efficiency to navigate current market conditions and position itself for future growth.
The most recent analyst rating on (GB:IQE) stock is a Hold with a £9.50 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc has issued a trading update indicating a revenue forecast for the financial year ending December 31, 2025, expected to be between £90.0m to £100.0m, with an adjusted EBITDA ranging from £(5.0)m to £2.0m. The announcement also highlights that revenue for the first half of 2025 is anticipated to be at least £44.0m with an adjusted LBITDA of £(0.4)m, reflecting the company’s ongoing strategic review and market positioning efforts.
The most recent analyst rating on (GB:IQE) stock is a Hold with a £9.50 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc announced that its Executive Chair, Mark Cubitt, has been granted nil cost share options over 166,667 ordinary shares as part of the company’s Long Term Incentive Plan. This grant is part of a series of planned awards, potentially reaching up to 666,667 shares, aimed at aligning leadership incentives with company performance. This strategic move underscores IQE’s commitment to retaining key leadership and enhancing its market position in the semiconductor industry.
The most recent analyst rating on (GB:IQE) stock is a Hold with a £9.50 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc announced that as of 31 August 2025, its issued share capital comprised 976,708,616 ordinary shares, with 4,115 held in treasury, resulting in 976,704,501 shares with voting rights. This figure is crucial for shareholders to determine their notification requirements under the Financial Conduct Authority’s rules, impacting how stakeholders manage their interests in the company.
The most recent analyst rating on (GB:IQE) stock is a Hold with a £9.50 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.